Pulse Biosciences, Inc. PLSE Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $30.89M— | $32.03M— | $34.3M— | $31.47M— | —— | ||
| -$74.57M-23.8% | -$72.78M-35.8% | -$74.73M-62.0% | -$68.03M-54.5% | -$60.24M-41.6% | ||
| -$77M-23.0% | -$75.86M-37.6% | -$77.84M-64.3% | -$71.13M-58.1% | -$62.58M-43.9% | ||
| -$78.05M-22.5% | -$76.94M-36.8% | -$78.95M-62.7% | -$72.24M-56.6% | -$63.69M-42.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s profit margins?
- Gross margin is -4067.5% and operating margin is -10392.1%, with a -9929.0% net margin.
- Where does Pulse Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.